ko728 44
JAN 18 2008
14.0 510(k) Safety Summary
A. Name of Device
Trade Name: ThermaCool NXT Multiplex Assembly
Common Name: Electrosurgical Unit and Accessories
Classification Name: Device, Electrosurgical Cutting and Coagulation and
Accessories (21 CFR 878.4400)
Contact Person: Pamela M. Buckman, RN, MS
Vice President of Regulatory/Clinical Affairs
B. Predicate Device
Se
K033942
: K032088
Components and accessories K031046
compatible with the ThermaCool K043402
System (Model NXT) K051710
K052778
C. Device Description
The Multiplex Assembly is a 4-electode design incorporating four 3.00-cm’
electrode footprints with required spacing. The tip is fabricated from the same
materials as the previous tips, with the addition of a ceramic coolant spreader. Tip
fabrication wili be performed in the same manner and the treatment procedure will
be similar to previous methods. The Handpiece, Coupling Fluid, Return Pad and
Skin Marking Paper have been modified to accommodate the larger tip dimensions.
D. Indicated Use
The Thermage ThermaCool NXT Multiplex Assembly, including accessories and all
components, is indicated for use in dermatologic and general surgical procedures for
electrocoagulation and hemostasis, non-invasive treatment of periorbital wrinkles
and thytids including upper and lower eyelids, non invasive treatment of wrinkles
and rhytids, temporary improvement in the appearance of cellulite, temporary
improvement in local circulation, i-e., blood circulation, relief of minor muscle aches
and pains, relief of muscle spasms.
Page 20 of 174

+9 PC
ko? LF
E. Technical characteristics
The technological characteristics of the Multiplex Assembly, components and
accessories are substantially equivalent to those of the standard NXT Assembly,
components and accessories.
F. Summary
By virtue of design, principle of operation, materials and intended use, the Multiplex
Assembly is substantially equivalent to devices currently cleared for marketing in the
United States.
Page 21 of 174

2 M6 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
mr Food and Drug Administration
9200 Corporate Boulevard
JAN 1.8 2008 Rockville MD 20850
Thermage, Inc
% Ms. Pamela M. Buckman, RN MS
Vice President of Regulatory
Clinical Affairs
25881 Industrial Boulevard
Hayward, California 94545
Re: K072849
Trade/Device Name: Thermage ThermaCool System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories.
Regulatory Class: Class II
Product Code: GEI
Dated: January 14 2008
Received: January 15, 2008
Dear Ms. Buckman:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Pamela M. Buckman, RN, MS
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions regarding postmarket surveillance,
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket
Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events
(Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems
at (240) 276-3464. You may obtain other general information on your responsibilities under the
Act from the Division of Small Manufacturers, International and Consumer Assistance
at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
http://www. fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mak A Mellon —

Mark N. Melkerson

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

2.0 Indications for Use Statement

510(k) NUMBER (IF KNOWN): Ko 72)°'7F

DEVICE NAME: Thermage ThermaCool System

INDICATIONS FOR USE:

The Thermage ThermaCool System is indicated for use in Dermatologic and General

Surgical procedures for electrocoagulation and hemostasis.

Non-invasive treatment of periorbital wrinkles and rhytids including upper and lower

eyelids

Non-invasive treatment of wrinkles and rhytids

Temporary improvement in the appearance of cellulite

Relief of minor muscle aches and pains

Relief of muscle spasms

Temporary improvement of local circulation (i.c., blood circulation)

Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X pe Over-The-Counter-Use
(Per 21 CER 801.109) Sula AL, ( ) We AW’)
(Division Sign-Off) “ _
Division of General, Restorative,
and Neurdidgiai Devices Page 5 of 174
: NG iG

510(k) Number_<07 29444

